Posted in Web FDA approves Journavx, new non-opioid painkiller from Vertex January 31, 2025 Nonetheless, Vertex executives say Journavx’s ability to soothe pain without the risk of addiction will likely make it a blockbuster, a drug that generates sales of at least $1 billion a year. https://www.bostonglobe.com/2025/01/30/business/fda-approves-journavx-new-non-opioid-painkiller-vertex-an-important-public-health-milestone/